The Cleveland Clinic Foundation
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary, Private
- Established
- 1921-01-01
- Employees
- 1K
- Market Cap
- -
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
Phase 2
Withdrawn
- Conditions
- Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- The Cleveland Clinic
- Registration Number
- NCT00112879
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor
Phase 1
- Conditions
- Metastatic Cancer
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 62
- Registration Number
- NCT00107367
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
Phase 1
- Conditions
- Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous ConditionUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-09-13
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT00004036
- Locations
- 🇺🇸
Cleveland Clinic Cancer Center, Cleveland, Ohio, United States
Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2004-05-21
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT00003490
- Locations
- 🇺🇸
Cleveland Clinic Cancer Center, Cleveland, Ohio, United States
Rituximab in Treating Patients With Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2004-04-30
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- The Cleveland Clinic
- Registration Number
- NCT00003554
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Combination Chemotherapy in Treating Patients With Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- The Cleveland Clinic
- Registration Number
- NCT00003493
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Biological Therapy in Treating Patients With Glioblastoma Multiforme
Phase 2
Completed
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-02-09
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 40
- Registration Number
- NCT00003185
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Reiki/Energy Healing in Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: ReikiBehavioral: Pretend ReikiBehavioral: Rest / Guided Imagery
- First Posted Date
- 2003-07-22
- Last Posted Date
- 2012-09-24
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 79
- Registration Number
- NCT00065208
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
Phase 2
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 73
- Registration Number
- NCT00054496
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy
Phase 1
- Conditions
- Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- The Cleveland Clinic
- Registration Number
- NCT00022425
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath